 |
 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 January 2002 | Volume 136 Issue 1 | Pages 1-12
Background: Oral glucocorticoids combined with disease-modifying antirheumatic drugs are beneficial and retard radiologic joint damage in rheumatoid arthritis.
Objective: To investigate the clinical efficacy, disease-modifying properties, and side effects of low-dose glucocorticoids as monotherapy for previously untreated patients with early active rheumatoid arthritis.
Design: 2-year randomized, double-blind, placebo-controlled clinical trial.
Setting: 2 outpatient rheumatology clinics.
Patients: 81 patients with early active rheumatoid arthritis who had not been treated with disease-modifying antirheumatic drugs.
Intervention: 41 patients were assigned to 10 mg of oral prednisone per day, and 40 were assigned to placebo. Nonsteroidal anti-inflammatory drugs were allowed in both groups. After 6 months, sulfasalazine (2 g/d) could be prescribed as rescue medication.
Measurements: Clinical variables were assessed at baseline and every 3 months; radiologic studies were performed every 6 months. Adverse effects were documented every 3 months.
Results: In the first 6 months, the prednisone group showed more clinical improvement than the placebo group. This effect was not seen after 6 months except in grip strength and the 28-joint score for tenderness. Use of additional therapies was significantly less common in the prednisone group, particularly in the first 6 months. More than 65% of those who completed the study were not taking sulfasalazine. After month 6, radiologic scores showed significantly less progression in the prednisone group than in the placebo group. No clinically relevant adverse effects were observed, except for a higher incidence of osteoporotic fractures in the prednisone group.
Conclusions: Prednisone, 10 mg/d, provides clinical benefit, particularly in the first 6 months, and substantially inhibits progression of radiologic joint damage in patients with early active rheumatoid arthritis and no previous treatment with disease-modifying antirheumatic drugs. Because of their limited disease-modifying effects, glucocorticoids should be combined with disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
Author and Article Information
From University Medical Center Utrecht, Utrecht; Deventer Hospital, Deventer; and Zutphen Hospital, Zutphen, the Netherlands.
Acknowledgments: The authors thank H.H. Nuver-Zwart, rheumatologist, for patient inclusion and support and B.G. Ziedzes des Plantes, radiologist, for advice; E.M.J. Brouwers-Kuyper, radiologist, and D.M. Hofman, rheumatologist, for scoring the radiographs; the Deventer Hospital pharmacists for preparation, randomization, and distribution of the study medication; and A.W.J.M. Jacobs-van Bree for data management.
Grant Support: By the Dutch League against Rheumatism (Het Nationaal Reumafonds) (no. 541).
Requests for Single Reprints: Johannes W.G. Jacobs, MD, Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, F02.127, Box 85500, 3508 GA Utrecht, the Netherlands; e-mail, j.w.g.jacobs{at}azu.nl.
Current Author Addresses: Dr. van Everdingen: Department of Rheumatology, Deventer Hospital, Box 5001, 7400 GC Deventer, the Netherlands.
Dr. Jacobs: Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, F02.127, Box 85500, 3508 GA Utrecht, the Netherlands.
Dr. Siewertsz van Reesema: Department of Rheumatology, Deventer Hospital, Box 5001, 7400 GC Deventer, the Netherlands.
Dr. Bijlsma: Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, F02.127, Box 85500, 3508 GA Utrecht, the Netherlands.
Author Contributions: Conception and design: A.A. van Everdingen, J.W.G. Jacobs, D.R. Siewertsz van Reesema, J.W.J. Bijlsma.
Analysis and interpretation of the data: A.A. van Everdingen, J.W.G. Jacobs, D.R. Siewertsz van Reesema, J.W.J. Bijlsma.
Drafting of the article: A.A. van Everdingen, J.W.G. Jacobs, D.R. Siewertsz van Reesema.
Critical revision of the article for important intellectual content: A.A. van Everdingen, J.W.G. Jacobs, D.R. Siewertsz van Reesema, J.W.J. Bijlsma.
Final approval of the article: A.A. van Everdingen, J.W.G. Jacobs, D.R. Siewertsz van Reesema, J.W.J. Bijlsma.
Provision of study materials or patients: A.A. van Everdingen, J.W.G. Jacobs.
Statistical expertise: A.A. van Everdingen, J.W.G. Jacobs.
Obtaining of funding: A.A. van Everdingen, J.W.J. Bijlsma.
Administrative, technical, or logistic support: A.A. van Everdingen, J.W.G. Jacobs, J.W.J. Bijlsma.
Collection and assembly of data: A.A. van Everdingen, J.W.G. Jacobs. ARTICLE
Low-Dose Prednisone Therapy for Patients with Early Active Rheumatoid Arthritis: Clinical Efficacy, Disease-Modifying Properties, and Side Effects: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  E H S Choy, C M Smith, V Farewell, D Walker, A Hassell, L Chau, D L Scott, and for the CARDERA (Combination Anti-Rheumatic Drugs Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis Ann Rheum Dis, May 1, 2008; 67(5): 656 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Iikuni, E. Inoue, E. Tanaka, M. Hara, T. Tomatsu, N. Kamatani, and H. Yamanaka Low disease activity state with corticosteroid may not represent 'true' low disease activity state in patients with rheumatoid arthritis Rheumatology, April 1, 2008; 47(4): 519 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Aletaha, V Strand, J S Smolen, and M M Ward Treatment-related improvement in physical function varies with duration of rheumatoid arthritis: a pooled analysis of clinical trial results Ann Rheum Dis, February 1, 2008; 67(2): 238 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. M. Wasko, H. B. Hubert, V. B. Lingala, J. R. Elliott, M. E. Luggen, J. F. Fries, and M. M. Ward Risk of Diabetes in Patients With Rheumatoid Arthritis Taking Hydroxychloroquine Reply JAMA, November 28, 2007; 298(20): 2369 - 2370. [Full Text] [PDF]
|
|
|
|
|
|
J W J Bijlsma and M E Weinblatt Optimal use of methotrexate: the advantages of tight control Ann Rheum Dis, November 1, 2007; 66(11): 1409 - 1410. [Full Text] [PDF]
|
|
|
|
|
|
J. Grisar, D. Aletaha, C. W Steiner, T. Kapral, S. Steiner, M. Saemann, I. Schwarzinger, B. Buranyi, G. Steiner, and J. S Smolen Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy Ann Rheum Dis, October 1, 2007; 66(10): 1284 - 1288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Fardet, J. Cabane, A. Kettaneh, C. Lebbe, and A. Flahault Corticosteroid-induced lipodystrophy is associated with features of the metabolic syndrome Rheumatology, July 1, 2007; 46(7): 1102 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Scott Early rheumatoid arthritis Br. Med. Bull., May 31, 2007; (2007) ldm011v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Baron, I. Boutron, B. Giraudeau, and P. Ravaud Reporting of radiographic methods in randomised controlled trials assessing structural outcomes in rheumatoid arthritis Ann Rheum Dis, May 1, 2007; 66(5): 651 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B Combe, R Landewe, C Lukas, H D Bolosiu, F Breedveld, M Dougados, P Emery, G Ferraccioli, J M W Hazes, L Klareskog, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) Ann Rheum Dis, January 1, 2007; 66(1): 34 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Capellino, B Riepl, L Rauch, P Angele, M Cutolo, and R H Straub Quantitative determination of steroid hormone receptor positive cells in the synovium of patients with rheumatoid arthritis and osteoarthritis: is there a link to inflammation? Ann Rheum Dis, January 1, 2007; 66(1): 53 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gaffo, K. G. Saag, and J. R. Curtis Treatment of rheumatoid arthritis Am. J. Health Syst. Pharm., December 15, 2006; 63(24): 2451 - 2465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Combination therapy for early rheumatoid arthritis DTB, November 1, 2006; 44(11): 81 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S M M Verstappen, J N Hoes, E J ter Borg, J W J Bijlsma, A A M Blaauw, G A van Albada-Kuipers, C van Booma-Frankfort, J W G Jacobs, and on behalf of the Utrecht Rheumatoid Arthritis Coho Joint surgery in the Utrecht Rheumatoid Arthritis Cohort: the effect of treatment strategy Ann Rheum Dis, November 1, 2006; 65(11): 1506 - 1511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z N Jahangier, K M G Jacobs, J W J Bijlsma, and F P J G Lafeber Radiation synovectomy with yttrium-90 for persisting arthritis has direct harmful effects on human cartilage that cannot be prevented by co-administration of glucocorticoids: an in vitro study Ann Rheum Dis, October 1, 2006; 65(10): 1384 - 1389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Morrison and H. A. Capell Corticosteroids in the management of early and established rheumatoid disease Rheumatology, September 1, 2006; 45(9): 1058 - 1061. [Full Text] [PDF]
|
|
|
|
|
|
D. Aeberli, M. Leech, and E. F. Morand Macrophage migration inhibitory factor and glucocorticoid sensitivity Rheumatology, August 1, 2006; 45(8): 937 - 943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Saha, R. Siva, C. E. Brightling, and I. D. Pavord COPD: an inhaled corticosteroid-resistant, oral corticosteroid-responsive condition. Eur. Respir. J., April 1, 2006; 27(4): 863 - 865. [Full Text] [PDF]
|
|
|
|
|
|
J A P Da Silva, J W G Jacobs, J R Kirwan, M Boers, K G Saag, L B S Ines, E J P de Koning, F Buttgereit, M Cutolo, H Capell, et al. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data Ann Rheum Dis, March 1, 2006; 65(3): 285 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Aletaha and M M Ward Duration of rheumatoid arthritis influences the degree of functional improvement in clinical trials Ann Rheum Dis, February 1, 2006; 65(2): 227 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Matthay and C. S. Calfee Therapeutic Value of a Lung Protective Ventilation Strategy in Acute Lung Injury Chest, November 1, 2005; 128(5): 3089 - 3091. [Full Text] [PDF]
|
|
|
|
|
|
E H Choy, G H Kingsley, B Khoshaba, N Pipitone, D L Scott, and the Intramuscular Methylprednisolone Study Group A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs Ann Rheum Dis, September 1, 2005; 64(9): 1288 - 1293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Haugeberg, A. Strand, T. K. Kvien, and J. R. Kirwan Reduced Loss of Hand Bone Density With Prednisolone in Early Rheumatoid Arthritis: Results From a Randomized Placebo-Controlled Trial Arch Intern Med, June 13, 2005; 165(11): 1293 - 1297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pisu, N. James, S. Sampsel, and K. G. Saag The cost of glucocorticoid-associated adverse events in rheumatoid arthritis Rheumatology, June 1, 2005; 44(6): 781 - 788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Kirwan, M Boers, H Capell, J Hunter, R Madhok, E Morrison, J Larkin, and on behalf of the WOSERACT group Low dose prednisolone for treatment of RA * Authors' reply Ann Rheum Dis, November 1, 2004; 63(11): 1533 - 1534. [Full Text] [PDF]
|
|
|
|
|
|
H A Capell, R Madhok, J A Hunter, D Porter, E Morrison, J Larkin, E A Thomson, R Hampson, and F W Poon Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial Ann Rheum Dis, July 1, 2004; 63(7): 797 - 803. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. O'Dell Therapeutic Strategies for Rheumatoid Arthritis N. Engl. J. Med., June 17, 2004; 350(25): 2591 - 2602. [Full Text] [PDF]
|
|
|
|
|
|
P P Geusens, R N J de Nijs, W F Lems, R F J M Laan, A Struijs, T P van Staa, and J W J Bijlsma Prevention of glucocorticoid osteoporosis: a consensus document of the Dutch Society for Rheumatology Ann Rheum Dis, March 1, 2004; 63(3): 324 - 325. [Full Text] [PDF]
|
|
|
|
|
|
F C Breedveld, P Emery, E Keystone, K Patel, D E Furst, J R Kalden, E W St Clair, M Weisman, J Smolen, P E Lipsky, et al. Infliximab in active early rheumatoid arthritis Ann Rheum Dis, February 1, 2004; 63(2): 149 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J W J Bijlsma, M Boers, K G Saag, and D E Furst Glucocorticoids in the treatment of early and late RA Ann Rheum Dis, November 1, 2003; 62(11): 1033 - 1037. [Full Text] [PDF]
|
|
|
|
|
|
M Cutolo, B Seriolo, C Craviotto, C Pizzorni, and A Sulli Circadian rhythms in RA Ann Rheum Dis, July 1, 2003; 62(7): 593 - 596. [Full Text] [PDF]
|
|
|
|
|
|
H Forsblad d'Elia, A Larsen, E Waltbrand, G Kvist, D Mellstrom, T Saxne, C Ohlsson, E Nordborg, and H Carlsten Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis Ann Rheum Dis, July 1, 2003; 62(7): 617 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-C. Bae, M. Corzillius, K. M. Kuntz, and M. H. Liang Cost-effectiveness of low dose corticosteroids versus non-steroidal anti-inflammatory drugs and COX-2 specific inhibitors in the long-term treatment of rheumatoid arthritis Rheumatology, January 1, 2003; 42(1): 46 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Pincus, G. Ferraccioli, T. Sokka, A. Larsen, R. Rau, I. Kushner, and F. Wolfe Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review Rheumatology, December 1, 2002; 41(12): 1346 - 1356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M H Weisman Newly diagnosed rheumatoid arthritis Ann Rheum Dis, April 1, 2002; 61(4): 287 - 289. [Full Text] [PDF]
|
|
|
|
 |
|
 Low-Dose Steroids to Prevent RA Disease Progression? Journal Watch Gastroenterology, March 12, 2002; 2002(312): 13 - 13. [Full Text]
|
|
|
|
 |
|
 Low-Dose Steroids to Prevent RA Disease Progression? Journal Watch (General), January 22, 2002; 2002(122): 1 - 1. [Full Text]
|
|
|
|
 |
|
 T. Pincus, T. Sokka, and C. M. Stein Are Long-Term Very Low Doses of Prednisone for Patients with Rheumatoid Arthritis as Helpful as High Doses Are Harmful? Ann Intern Med, January 1, 2002; 136(1): 76 - 78. [Full Text] [PDF]
|
|
Article
